Barbara Wirostko - Net Worth and Insider Trading

Barbara Wirostko Net Worth

The estimated net worth of Barbara Wirostko is at least $303 dollars as of 2024-11-11. Barbara Wirostko is the Chief Medical Officer of Kiora Pharmaceuticals Inc and owns about 86 shares of Kiora Pharmaceuticals Inc (KPRX) stock worth over $303. Details can be seen in Barbara Wirostko's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Barbara Wirostko has not made any transactions after 2019-07-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Barbara Wirostko

To

Barbara Wirostko Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Barbara Wirostko owns 1 companies in total, including Kiora Pharmaceuticals Inc (KPRX) .

Click here to see the complete history of Barbara Wirostko’s form 4 insider trades.

Insider Ownership Summary of Barbara Wirostko

Ticker Comapny Transaction Date Type of Owner
KPRX Kiora Pharmaceuticals Inc 2019-07-15 Chief Medical Officer

Barbara Wirostko Latest Holdings Summary

Barbara Wirostko currently owns a total of 1 stock. Barbara Wirostko owns 86 shares of Kiora Pharmaceuticals Inc (KPRX) as of July 15, 2019, with a value of $303.

Latest Holdings of Barbara Wirostko

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KPRX Kiora Pharmaceuticals Inc 2019-07-15 86 3.53 303

Holding Weightings of Barbara Wirostko


Barbara Wirostko Form 4 Trading Tracker

According to the SEC Form 4 filings, Barbara Wirostko has made a total of 0 transactions in Kiora Pharmaceuticals Inc (KPRX) over the past 5 years. The most-recent trade in Kiora Pharmaceuticals Inc is the sale of 4 shares on July 15, 2019, which brought Barbara Wirostko around $4,671.

Insider Trading History of Barbara Wirostko

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Barbara Wirostko Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Barbara Wirostko Ownership Network

Ownership Network List of Barbara Wirostko

No Data

Ownership Network Relation of Barbara Wirostko

Insider Network Chart

Barbara Wirostko Owned Company Details

What does Kiora Pharmaceuticals Inc do?

Who are the key executives at Kiora Pharmaceuticals Inc?

Barbara Wirostko is the Chief Medical Officer of Kiora Pharmaceuticals Inc. Other key executives at Kiora Pharmaceuticals Inc include EVP of Finance Melissa Tosca , Chief Development Officer Eric Joseph Daniels , and director & President and CEO Brian M. Strem .

Kiora Pharmaceuticals Inc (KPRX) Insider Trades Summary

Over the past 18 months, Barbara Wirostko made no insider transaction in Kiora Pharmaceuticals Inc (KPRX). Other recent insider transactions involving Kiora Pharmaceuticals Inc (KPRX) include a net purchase of 2,100 shares made by Melissa Tosca , a net purchase of 5,260 shares made by Erin Parsons , and a net purchase of 5,000 shares made by Praveen Tyle .

In summary, during the past 3 months, insiders sold 0 shares of Kiora Pharmaceuticals Inc (KPRX) in total and bought 12,500 shares, with a net purchase of 12,500 shares. During the past 18 months, 0 shares of Kiora Pharmaceuticals Inc (KPRX) were sold and 22,291 shares were bought by its insiders, resulting in a net purchase of 22,291 shares.

Kiora Pharmaceuticals Inc (KPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kiora Pharmaceuticals Inc Insider Transactions

No Available Data

Barbara Wirostko Mailing Address

Above is the net worth, insider trading, and ownership report for Barbara Wirostko. You might contact Barbara Wirostko via mailing address: C/o Eyegate Pharmaceuticals, Inc., 271 Waverly Oaks Road, Suite 108, Waltham Ma 02452.